TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
22,411,301
|
17,773,699
|
15,144,226 |
| Financial expenses |
1,177,143
|
470,119
|
442,751 |
| Earnings before taxes |
2,992,496
|
3,141,376
|
3,213,357 |
| EBITDA |
7,328,271
|
5,757,770
|
5,590,949 |
| Total assets |
74,991,699
|
49,656,632
|
47,455,288 |
| Current assets |
12,836,125
|
10,604,627
|
8,560,501 |
| Current liabilities |
19,343,841
|
14,053,425
|
8,543,922 |
| Equity capital |
34,308,345
|
25,090,334
|
22,628,081 |
| - share capital |
196,528
|
160,805
|
164,813 |
| Employees (average) |
1,772
|
1,556
|
1,559 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
45.7%
|
50.5%
|
47.7% |
| Turnover per employee |
12,647
|
11,423
|
9,714 |
| Profit as a percentage of turnover |
13.4%
|
17.7%
|
21.2% |
| Return on assets (ROA) |
5.6%
|
7.3%
|
7.7% |
| Current ratio |
66.4%
|
75.5%
|
100.2% |
| Return on equity (ROE) |
8.7%
|
12.5%
|
14.2% |
| Change turnover |
3,376,435
|
3,084,621
|
261,360 |
| Change turnover % |
18%
|
21%
|
2% |
| Chg. No. of employees |
216
|
-3
|
50 |
| Chg. No. of employees % |
14%
|
0%
|
3% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.